Shanghai Runda Medical Technology Co., Ltd. (SHA:603108)

China · Delayed Price · Currency is CNY

10.68

-0.38 (-3.44%)

Aug 11, 2026, 3:00 PM CST

SHA:603108 Financials Overview

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	6,847	6,999	8,312	9,147	10,494	8,860
Revenue Growth	-13.34%	-15.80%	-9.13%	-12.84%	18.45%	25.34%
Gross Profit	1,503	1,497	2,101	2,416	2,931	2,392
Operating Income	24.65	1.62	563.03	713.53	978.14	949.16
Net Income	-532.7	-548.39	55.28	273.3	417.75	380.23
Earnings Per Share	-0.90	-0.91	0.09	0.47	0.70	0.64
EPS Growth	-	-	-80.85%	-32.86%	9.38%	12.28%

Revenue by Segment

Fiscal Year	FY 2025
Period Ending	Dec '25 Dec 31, 2025
Industry (Own Brand)	458.21
Commerce (Distribution Services)	6,532
Total	6,991

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	970.03	1,146	1,289	1,126	1,114	1,049
Total Debt	6,791	6,864	7,046	6,751	6,889	5,698
Net Cash (Debt)	-5,821	-5,719	-5,757	-5,625	-5,776	-4,649
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-9.80	-9.49	-9.37	-9.67	-9.68	-7.83

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	566.73	637.22	646.95	729.72	-428.86	371.11
Capital Expenditures	-268.83	-250.48	-229.16	-319.88	-272.12	-301.09
Free Cash Flow	297.9	386.74	417.78	409.84	-700.98	70.03
Free Cash Flow Growth	-48.90%	-7.43%	1.94%	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	21.95%	21.39%	25.28%	26.41%	27.93%	27.00%
Operating Margin	0.36%	0.02%	6.77%	7.80%	9.32%	10.71%
Pretax Margin	-6.54%	-6.58%	4.16%	7.17%	7.81%	8.81%
Profit Margin	-7.78%	-7.84%	0.66%	2.99%	3.98%	4.29%
FCF Margin	4.35%	5.53%	5.03%	4.48%	-6.68%	0.79%

Dividends

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Dividend Per Share	0.030	-	0.030	0.100	0.150
Dividend Per Share Growth	-70.00%	-	-70.00%	-33.33%	-
Dividend Yield	0.28%	-	0.19%	0.50%	1.51%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 11, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	-	-	172.58	43.63	14.03	20.44
Forward PE	-	90.61	21.33	21.20	13.66	15.50
P/FCF Ratio	22.41	23.34	22.84	29.09	-	110.98
PS Ratio	0.98	1.29	1.15	1.30	0.56	0.88